Maynard Um
-
-
-
-
-
-
-
Lexeo Therapeutics' (LXEO) PKP2-ACM Program Under the Radar - Cantor Fitzgerald
-
-
-
-
-
-
-
Lexeo Therapeutics (LXEO) PT Lowered to $18 at Stifel
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Lexeo Therapeutics (LXEO)
-
-
-
-
-
-
-
Lexeo Therapeutics, Inc. (LXEO) Misses Q1 EPS by 10c
-
-
-
-
-
-
-
Lexeo Therapeutics (LXEO) Appoints Kyle Rasbach as CFO
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Lexeo Therapeutics (LXEO)
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

